XKRX:950220 (USA)
Â
Korean Depository Receipts
â‚©
1111.00
(+1%)
Dec 27
Business Description
NeoImmuneTech Inc
NAICS : 541714
SIC : 2834
ISIN : KR8840140006
Share Class Description:
XKRX:950220: Korean Depository ReceiptsCompare
Compare
Traded in other countries / regions
950220.Korea IPO Date
2021-03-16Description
NeoImmuneTech Inc is a clinical-stage T cell-focused biotech company dedicated to the discovery and development of novel immuno-therapeutics. Its lead asset NT-I7 is the clinical stage IL-7, which enhances the body's immune function to address key resistance mechanisms in Immuno-Oncology and deadly infectious diseases.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.66 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.11 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -6.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -12.5 | |||||
| 3-Year EPS without NRI Growth Rate | -13.4 | |||||
| 3-Year FCF Growth Rate | -12.2 | |||||
| 3-Year Book Growth Rate | -9.4 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.29 | |||||
| 9-Day RSI | 41.02 | |||||
| 14-Day RSI | 41.02 | |||||
| 6-1 Month Momentum % | -25.67 | |||||
| 12-1 Month Momentum % | -34.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.12 | |||||
| Quick Ratio | 4.12 | |||||
| Cash Ratio | 3.66 | |||||
| Days Sales Outstanding | 356.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.1 | |||||
| Shareholder Yield % | 4.42 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -4160.6 | |||||
| Net Margin % | -4033.49 | |||||
| FCF Margin % | -3826.55 | |||||
| ROE % | -65.77 | |||||
| ROA % | -52.42 | |||||
| ROIC % | -155.09 | |||||
| ROC (Joel Greenblatt) % | -589.43 | |||||
| ROCE % | -59.53 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 19.82 | |||||
| PB Ratio | 0.48 | |||||
| Price-to-Tangible-Book | 0.55 | |||||
| EV-to-EBIT | 0.33 | |||||
| EV-to-EBITDA | 0.35 | |||||
| EV-to-Revenue | -13.12 | |||||
| EV-to-FCF | 0.33 | |||||
| Price-to-Net-Current-Asset-Value | 1.16 | |||||
| Price-to-Net-Cash | 1.59 | |||||
| Earnings Yield (Greenblatt) % | 295.08 | |||||
| FCF Yield % | -189.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NeoImmuneTech Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 1,090.765 | ||
| EPS (TTM) (â‚©) | -2220 | ||
| Beta | 1.67 | ||
| Volatility % | 48.14 | ||
| 14-Day RSI | 41.02 | ||
| 14-Day ATR (â‚©) | 55.631423 | ||
| 20-Day SMA (â‚©) | 1147.35 | ||
| 12-1 Month Momentum % | -34.23 | ||
| 52-Week Range (â‚©) | 999 - 2130 | ||
| Shares Outstanding (Mil) | 19.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NeoImmuneTech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NeoImmuneTech Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
NeoImmuneTech Inc Frequently Asked Questions
What is NeoImmuneTech Inc(XKRX:950220)'s stock price today?
The current price of XKRX:950220 is â‚©1111.00. The 52 week high of XKRX:950220 is â‚©2130.00 and 52 week low is â‚©999.00.
When is next earnings date of NeoImmuneTech Inc(XKRX:950220)?
The next earnings date of NeoImmuneTech Inc(XKRX:950220) is 2025-02-14 Est..
Does NeoImmuneTech Inc(XKRX:950220) pay dividends? If so, how much?
NeoImmuneTech Inc(XKRX:950220) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers